[HTML][HTML] Measuring quality of life in diabetic retinal disease: a narrative review of available patient-reported outcome measures
Topic Several patient-reported outcome measures (PROMs) are available to measure health-
related quality of life (HRQoL) in patients with late-stage clinical diabetic retinal diseases …
related quality of life (HRQoL) in patients with late-stage clinical diabetic retinal diseases …
Preferences and health-related quality-of-life related to disease and treatment features for patients with hemophilia A in a canadian general population sample
K Johnston, JM Stoffman, AT Mickle… - Patient preference …, 2021 - Taylor & Francis
Background Current treatments for hemophilia A in Canada include on-demand treatment
as bleeds occur and regular intravenous prophylactic factor VIII (FVIII) infusions. The …
as bleeds occur and regular intravenous prophylactic factor VIII (FVIII) infusions. The …
[HTML][HTML] Photodynamic versus white-light-guided resection of first-diagnosis non-muscle-invasive bladder cancer: PHOTO RCT.
R Heer, R Lewis, A Duncan, S Penegar… - Health technology …, 2022 - ncbi.nlm.nih.gov
BACKGROUND Around 7500 people are diagnosed with non-muscle-invasive bladder
cancer in the UK annually. Recurrence following transurethral resection of bladder tumour is …
cancer in the UK annually. Recurrence following transurethral resection of bladder tumour is …
Evaluating the outcomes associated with genomic sequencing: a roadmap for future research
J Buchanan, S Wordsworth - PharmacoEconomics-open, 2019 - Springer
The rapid pace of discovery in genomics has been remarkable. The first human genome
was sequenced as recently as 2003, costing between US $500 million and US $1 billion [1] …
was sequenced as recently as 2003, costing between US $500 million and US $1 billion [1] …
Endoscopic urethrotomy versus open urethroplasty for men with bulbar urethral stricture: the OPEN randomised trial cost-effectiveness analysis
Background Bulbar urethral stricture is a common cause for urinary symptoms in men and its
two main treatment options both have drawbacks with little evidence on their relative cost …
two main treatment options both have drawbacks with little evidence on their relative cost …
The power of hope: Views of Ovarian Cancer patients on how maintenance therapy Affects their Lives (VOCAL)
DM Chase, S Shukla, J Courcy, H Ellis, J Piercy… - Future …, 2024 - Taylor & Francis
Aim: To assess maintenance preference and trade-offs for patients with advanced epithelial
ovarian cancer. Methods: Patients completed a time trade-off exercise ranking five …
ovarian cancer. Methods: Patients completed a time trade-off exercise ranking five …
Completing the time trade-off with respondents who are older, in poorer health or with an immigrant background in an EQ-5D-5L valuation study
Objectives To determine the effects of age, immigrant background, and poor self-reported
health in a general population sample on the probability of non-completion or slow …
health in a general population sample on the probability of non-completion or slow …
Using time trade-off methods to elicit short-term utilities associated with treatments for bulbar urethral stricture
Background Recurrent urethral stricture is usually treated with either open urethroplasty or
endoscopic urethrotomy. Both of the procedures cause short-term utility loss, which may not …
endoscopic urethrotomy. Both of the procedures cause short-term utility loss, which may not …
Impact of Including Carer Information in Time Trade-Off Tasks: Results from a Pilot Study
Introduction Carer quality of life (QoL) can be included in economic evaluations and
captured using EQ-5D. Traditional valuation tasks require participants to imagine living in a …
captured using EQ-5D. Traditional valuation tasks require participants to imagine living in a …
[PDF][PDF] Preferences and health utilities related to disease and treatment features for patients with hemophilia A in Canada
K Johnston, J Stoffman, A Mickle, R Klaassen… - 2020 - assets-eu.researchsquare.com
Background: Hemophilia A is caused by a mutation of clotting factor genes resulting in a de
ciency of factor VIII (FVIII). Current treatments for hemophilia A in Canada include on …
ciency of factor VIII (FVIII). Current treatments for hemophilia A in Canada include on …